Back
Akebia Therapeutics Vs. Bioventus Industry Stock Comparison
Sell
36
AKBA
Akebia Therapeutics
Last Price:
1.37
Seasonality Move:
-2.71%
Buy
93
BVS
Bioventus
Last Price:
11.86
Seasonality Move:
0.38%
Sell
36
Akebia Therapeutics (AKBA)
is a Sell
Is Akebia Therapeutics a Buy, Sell or Hold?
- The current Akebia Therapeutics [AKBA] share price is $1.37. The Score for AKBA is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- AKBA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
93
Bioventus (BVS)
is a Buy
Is Bioventus a Buy, Sell or Hold?
- The current Bioventus [BVS] share price is $11.85. The Score for BVS is 93, which is 86% above its historic median score of 50, and infers lower risk than normal.
- BVS is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
AKBA Stock Price Chart
What is Akebia Therapeutics's stock price today?
-
The Akebia Therapeutics share price today is $1.37
The current trend is moderately bearish and AKBA is experiencing slight buying pressure.
AKBA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 46.8 | Sell |
| Chaikin Money Flow: | 264579 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.39 - 1.51) | Sell |
| Bollinger Bands (100): | (1.07 - 1.43) | Buy |
BVS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.86 | Buy |
| Relative Strength Index (14 RSI): | 75.1 | Buy |
| Chaikin Money Flow: | 957124 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.12 - 11.1) | Buy |
| Bollinger Bands (100): | (5.43 - 9.21) | Buy |
AKBA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.4 | Sell |
| 20-day SMA: | 1.44 | Sell |
| 50-day SMA: | 1.39 | Sell |
| 200-day SMA: | 1.37 | Buy |
| 8-day EMA: | 1.39 | Sell |
| 20-day EMA: | 1.41 | Sell |
| 50-day EMA: | 1.36 | Buy |
| 200-day EMA: | 1.3 | Buy |
BVS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.27 | Buy |
| 20-day SMA: | 10.45 | Buy |
| 50-day SMA: | 8.73 | Buy |
| 200-day SMA: | 6.1 | Buy |
| 8-day EMA: | 11.27 | Buy |
| 20-day EMA: | 10.45 | Buy |
| 50-day EMA: | 9.07 | Buy |
| 200-day EMA: | 6.55 | Buy |
Akebia Therapeutics Earnings Growth & AKBA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.01 per share, an increase this year of $0.14 per share, and an increase next year of $0.01 per share.
Bioventus Earnings Growth & BVS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.10 per share, an increase this year of $0.69 per share, and an increase next year of $0.20 per share.
Akebia Therapeutics Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bioventus Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||